期刊文献+

一种高效、稳定的可溶性原核表达载体的构建及应用 被引量:4

Construction and Application of an Efficient,Stable Soluble Prokaryotic Expression Vector
下载PDF
导出
摘要 以O型口蹄疫病毒结构蛋白VP1基因重组克隆载体pGEM-OVP1为模板,设计表达引物,经PCR扩增获得上游带有PelB信号肽编码序列的VP1 C端编码区,将其克隆至该表达载体pET-30a(+)中,构建了可溶性原核表达载体pET-30a-PelB-VP1C。将VP1全长编码区替换VP1C,获得重组原核表达载体pET-30a-PelB-VP1。将两种重组质粒分别转化大肠杆菌工程菌株BL21-(DE3)-plysS,经IPTG诱导表达,实现了VP1全长及其C端的可溶性表达,以金属离子螯合层析法分别对表达的VP1及其C端融合蛋白进行纯化,SDS-PAGE显示纯化的目的蛋白分别在32 ku和20 ku处有单一目的条带,具有较高的纯度。Western blot分析,VP1蛋白及其C端均可与牛O型口蹄疫病毒阳性血清反应。对重组菌株的连续传代实验证实了该可溶性表达载体的遗传稳定性,显示了该可溶性原核表达载体在蛋白可溶性表达中的应用价值。 In this study,the recombinant cloning vector pGEM-OVP1 was used as template for PCR to get the coding region of VP1 C terminus,and the coding region of PelB signal peptide coding region was added to the upstream of VP1C,then the fragment was cloned to prokaryotic expression vector to get recombinant expression plasmid pET-30a-PelB-VP1C.The VP1C fragment was replaced by the VP1 coding fragment to get pET-30a-PelB-VP1 expression plasmid.The E.Coli BL21-(DE3)-plysS was transformed respectively and solublely expressed fused VP1 and VP1 C terminus.Purified VP1 and VP1 C terminus were obtained by Ni-NTA His Bind Resin affinity chromatography and a single clear band of 32 ku and 20 ku appeared respectively in the SDS-PAGE gel.Western blot analysis showed that purified VP1 and VP1 C terminus could react with bovine antiserum against FMDV of serotype O.The consecutive culture of recombinant strains showed pET-30a-PelB-VP1C and pET-30a-PelB-VP1 has excellent stability,which had practical value in soluble protein expression.
出处 《华北农学报》 CSCD 北大核心 2009年第6期46-49,共4页 Acta Agriculturae Boreali-Sinica
基金 国家“十一五”重大科技支撑计划(2006BAD06A14)
关键词 口蹄疫病毒 原核表达 可溶性 信号肽 Foot-and-mouth disease virus Prokaryotic expression Soluble protein expression Signal peptide
  • 相关文献

参考文献11

  • 1Baneyx F. Recombinant protein expression in Escherichia coil [J]. Curr Opin Biotechnol, 1999,10(5 ) : 411 - 421.
  • 2Swartz J R. Advances in Eseherichia coli production of therapeutic proteins[J].Curr Opin Biotechnol,2001,12(2) : 195 - 201.
  • 3Makrides S C. Strategies for achieving high-level expression of genes in Escherichia coil [ J ]. Microbiol Rev, 1996,60 ( 3 ) : 512 - 538.
  • 4Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli[ J ]. Nat Biotechnol, 2004,22 ( 11 ) : 1399- 1408.
  • 5Singh S M, Panda A K. Solubilization and refolding of bacterial inclusion body proteins[J].J Biosci Bioeng, 2005,99 (4) : 303 - 310.
  • 6Choi J H, Lee S Y. Secretory and extracellular production of recombinant proteins using Escherichia coli [J].Appl Microbiol Biotechnol,2004,64(5) :625 - 635.
  • 7Lei S P, Lin H C, Wang S S, et al. Characterization of the Erwinia carotovora pelB gene and its product pectate lyase[ J]. J Bacteriol, 1987,169(9) :4379 - 4383.
  • 8周建华,丛国正,高闪电,常惠芸.FMDV OA/58病毒株VP1蛋白结构构建与B细胞抗原表位的预测[J].华北农学报,2007,22(4):176-179. 被引量:9
  • 9Pugsley A P. The complete general secretory, pathway in gramnegative bacteria[J]. Microbiol Rev, 1993,57( 1 ) :50 - 108.
  • 10Mergulhoo F J, Summers D K, Monteiro G A. Recombinant protein secretion in Escherichia coli [ J ]. Biotechnol Adv, 2005,23(3) :177 - 202.

二级参考文献7

  • 1Grubman M J,Baxt B.Foot-and-mouth disease[J].Clin Microbiol Rev,2004,17:465-493.
  • 2Knowles N J,Samuel P R.Molecular epidemiology of foot-and-mouth disease virus[J].Virus,2003,91:65-80.
  • 3Eric B,Carmen M,Ruiz-Jarabo,et al.Foot-and-mouth Disease Virus Lacking the VP1 G-H loop:The Mutant Spectrum Uncovers Interactions among Antigenic Site for Fitness Gain[J].Virology,2001,288:192-202.
  • 4Karplus P A,Schultz G E.Prediction of chain flexibility in proteins[J].Naturwissenschaften,1985,72:212-213.
  • 5Jameson B A,Wolf H.The antigenic index:a novel algorithmfor predicting antigenic determinants[J].Comput Appl Biosci,1988,4(1):181-186.
  • 6Petit M C,Benkirane N,Guichard G,et al.Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigen site structural basis for its antigenic cross-reactivity with the parent pepide[J].J Biol Chem,1999,274:3686-3692.
  • 7Apostolopoulos V,Yu M,Corper A L,et al.Crystal structure of a noncanonical low affinity peptide complexed with MHC class I:a new approach for vaccine design[J].J Mol Biol,2002,318(5):1293-1305.

共引文献8

同被引文献30

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部